The prevalence and management of anemia in chronic kidney disease patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOWCKD)

Sang Ryol Ryu, Sue K. Park, Ji Yong Jung, Yeong Hoon Kim, Yun Kyu Oh, Tae Hyun Yoo, Suah Sung

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Anemia is a common and significant complication of chronic kidney disease (CKD). However, its prevalence and current management status has not been studied thoroughly in Korea. We examined the prevalence of anemia, its association with clinical and laboratory factors, and utilization of iron agents and erythropoiesis stimulating agents using the baseline data from the large-scale CKD cohort in Korea. We defined anemia when hemoglobin level was lower than 13.0 g/dL in males and 12.0 g/dL in females, or received by erythropoiesis stimulating agents. Overall prevalence of anemia was 45.0% among 2,198 non-dialysis CKD patients from stage 1 to 5. Diabetic nephropathy (DN) as a cause, CKD stages, body mass index (BMI), smoking, leukocyte count, serum albumin, iron markers, calcium, and phosphorus concentration were identified as independent risk factors for anemia. Considering the current coverage of Korean National Health Insurance System, only 7.9% among applicable patients were managed by intravenous iron agents, and 42.7% were managed by erythropoiesis stimulating agents.

Original languageEnglish
Pages (from-to)249-256
Number of pages8
JournalJournal of Korean medical science
Volume32
Issue number2
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Chronic Renal Insufficiency
Anemia
Hematinics
Cohort Studies
Iron
Korea
National Health Programs
Diabetic Nephropathies
Leukocyte Count
Serum Albumin
Phosphorus
Hemoglobins
Body Mass Index
Smoking
Calcium

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{e374258ce10742b3903e1407119452a9,
title = "The prevalence and management of anemia in chronic kidney disease patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOWCKD)",
abstract = "Anemia is a common and significant complication of chronic kidney disease (CKD). However, its prevalence and current management status has not been studied thoroughly in Korea. We examined the prevalence of anemia, its association with clinical and laboratory factors, and utilization of iron agents and erythropoiesis stimulating agents using the baseline data from the large-scale CKD cohort in Korea. We defined anemia when hemoglobin level was lower than 13.0 g/dL in males and 12.0 g/dL in females, or received by erythropoiesis stimulating agents. Overall prevalence of anemia was 45.0{\%} among 2,198 non-dialysis CKD patients from stage 1 to 5. Diabetic nephropathy (DN) as a cause, CKD stages, body mass index (BMI), smoking, leukocyte count, serum albumin, iron markers, calcium, and phosphorus concentration were identified as independent risk factors for anemia. Considering the current coverage of Korean National Health Insurance System, only 7.9{\%} among applicable patients were managed by intravenous iron agents, and 42.7{\%} were managed by erythropoiesis stimulating agents.",
author = "Ryu, {Sang Ryol} and Park, {Sue K.} and Jung, {Ji Yong} and Kim, {Yeong Hoon} and Oh, {Yun Kyu} and Yoo, {Tae Hyun} and Suah Sung",
year = "2017",
month = "1",
day = "1",
doi = "10.3346/jkms.2017.32.2.249",
language = "English",
volume = "32",
pages = "249--256",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "2",

}

The prevalence and management of anemia in chronic kidney disease patients : Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOWCKD). / Ryu, Sang Ryol; Park, Sue K.; Jung, Ji Yong; Kim, Yeong Hoon; Oh, Yun Kyu; Yoo, Tae Hyun; Sung, Suah.

In: Journal of Korean medical science, Vol. 32, No. 2, 01.01.2017, p. 249-256.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The prevalence and management of anemia in chronic kidney disease patients

T2 - Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOWCKD)

AU - Ryu, Sang Ryol

AU - Park, Sue K.

AU - Jung, Ji Yong

AU - Kim, Yeong Hoon

AU - Oh, Yun Kyu

AU - Yoo, Tae Hyun

AU - Sung, Suah

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Anemia is a common and significant complication of chronic kidney disease (CKD). However, its prevalence and current management status has not been studied thoroughly in Korea. We examined the prevalence of anemia, its association with clinical and laboratory factors, and utilization of iron agents and erythropoiesis stimulating agents using the baseline data from the large-scale CKD cohort in Korea. We defined anemia when hemoglobin level was lower than 13.0 g/dL in males and 12.0 g/dL in females, or received by erythropoiesis stimulating agents. Overall prevalence of anemia was 45.0% among 2,198 non-dialysis CKD patients from stage 1 to 5. Diabetic nephropathy (DN) as a cause, CKD stages, body mass index (BMI), smoking, leukocyte count, serum albumin, iron markers, calcium, and phosphorus concentration were identified as independent risk factors for anemia. Considering the current coverage of Korean National Health Insurance System, only 7.9% among applicable patients were managed by intravenous iron agents, and 42.7% were managed by erythropoiesis stimulating agents.

AB - Anemia is a common and significant complication of chronic kidney disease (CKD). However, its prevalence and current management status has not been studied thoroughly in Korea. We examined the prevalence of anemia, its association with clinical and laboratory factors, and utilization of iron agents and erythropoiesis stimulating agents using the baseline data from the large-scale CKD cohort in Korea. We defined anemia when hemoglobin level was lower than 13.0 g/dL in males and 12.0 g/dL in females, or received by erythropoiesis stimulating agents. Overall prevalence of anemia was 45.0% among 2,198 non-dialysis CKD patients from stage 1 to 5. Diabetic nephropathy (DN) as a cause, CKD stages, body mass index (BMI), smoking, leukocyte count, serum albumin, iron markers, calcium, and phosphorus concentration were identified as independent risk factors for anemia. Considering the current coverage of Korean National Health Insurance System, only 7.9% among applicable patients were managed by intravenous iron agents, and 42.7% were managed by erythropoiesis stimulating agents.

UR - http://www.scopus.com/inward/record.url?scp=85011685225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011685225&partnerID=8YFLogxK

U2 - 10.3346/jkms.2017.32.2.249

DO - 10.3346/jkms.2017.32.2.249

M3 - Article

C2 - 28049235

AN - SCOPUS:85011685225

VL - 32

SP - 249

EP - 256

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 2

ER -